Robin Stevenson

Director/Board Member at Avelas Biosciences, Inc.

Health Technology

Health Services

Profile

Robin Stevenson is currently a Non-Executive Director at Avelas Biosciences, Inc. He started this position in 2021 and is still currently employed there.
Prior to this, he was a Director at The Breast Cancer Research Trust.

Robin Stevenson active positions

Companies	Position	Start
Avelas Biosciences, Inc. Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA.	Director/Board Member	18/10/2021

All active positions of Robin Stevenson

Former positions of Robin Stevenson

Companies	Position	End
The Breast Cancer Research Trust The Breast Cancer Research Trust Medical SpecialtiesHealth Technology The Breast Cancer Research Trust operates as not-for profit organization. It provides breast cancer treatment solutions. The company was founded in 1997 and is headquartered in Auckland, New Zealand.	Director/Board Member	-

See the detail of Robin Stevenson's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robin Stevenson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
The Breast Cancer Research Trust The Breast Cancer Research Trust Medical SpecialtiesHealth Technology The Breast Cancer Research Trust operates as not-for profit organization. It provides breast cancer treatment solutions. The company was founded in 1997 and is headquartered in Auckland, New Zealand.	Health Technology
Avelas Biosciences, Inc. Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA.	Health Services